Valneva SE Stock London S.E.
Stocks
0OB3
FR0004056851
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.592 EUR | -38.30% |
|
+15.92% | -30.05% |
| Market Cap | 409M 468M 377M 348M 655M 45.06B 670M 4.51B 1.77B 22.07B 1.76B 1.72B 75.97B | P/E 2026 * |
-5.87x | P/E 2027 * | 5.67x |
|---|---|---|---|---|---|
| Enterprise Value | 537M 614M 495M 457M 861M 59.16B 880M 5.92B 2.33B 28.98B 2.31B 2.26B 99.75B | EV / Sales 2026 * |
3.54x | EV / Sales 2027 * | 1.59x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Valneva SE
| 1 day | -38.30% | ||
| 1 week | +15.92% | ||
| Current month | +14.71% | ||
| 1 month | +14.02% | ||
| 3 months | +0.26% | ||
| 6 months | -39.69% | ||
| Current year | -30.05% |
| 1 week | 2.1 | 2.59 | |
| 1 month | 2.1 | 2.59 | |
| Current year | 2.1 | 5.15 | |
| 1 year | 2.1 | 5.42 | |
| 3 years | 1.72 | 7.14 | |
| 5 years | 1.72 | 29.54 | |
| 10 years | 1.72 | 29.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 2021-07-28 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2023-12-19 | |
James Sulat
BRD | Director/Board Member | 75 | 2013-03-06 |
| Chairman | 65 | 2023-12-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -38.30% | +15.92% | - | - | 468M | ||
| +3.90% | -0.39% | +376.72% | +599.59% | 39.58B | ||
| -1.70% | +4.46% | +7.46% | +57.67% | 34.69B | ||
| -2.01% | -0.76% | +26.35% | -6.83% | 34.42B | ||
| +0.06% | +0.34% | +2.32% | +29.30% | 27.11B | ||
| +0.46% | -3.49% | - | - | 16.21B | ||
| -0.04% | -0.09% | +68.48% | +117.39% | 15.36B | ||
| +1.12% | +1.91% | +15.90% | +19.65% | 14.05B | ||
| 0.00% | +1.36% | +15.74% | -30.62% | 13.02B | ||
| -0.08% | -3.01% | +1,271.69% | +649.69% | 11.76B | ||
| Average | -3.66% | +0.04% | +223.08% | +179.48% | 22.91B | |
| Weighted average by Cap. | +0.15% | +0.36% | +171.43% | +187.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152M 174M 140M 129M 243M 16.73B 249M 1.67B 659M 8.19B 652M 638M 28.21B | 294M 336M 271M 250M 471M 32.4B 482M 3.24B 1.28B 15.87B 1.26B 1.24B 54.63B |
| Net income | -66.01M -75.54M -60.92M -56.15M -106M -7.27B -108M -728M -286M -3.56B -284M -277M -12.26B | 70.5M 80.67M 65.06M 59.97M 113M 7.77B 116M 778M 306M 3.8B 303M 296M 13.1B |
| Net Debt | 128M 146M 118M 109M 205M 14.11B 210M 1.41B 555M 6.91B 550M 538M 23.78B | 60.02M 68.68M 55.38M 51.05M 96.22M 6.61B 98.35M 662M 260M 3.24B 258M 252M 11.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | €2.152 | -1.14% | 20,185 |
| 26-07-16 | €2.177 | -0.80% | 23,994 |
| 26-07-15 | €2.194 | +0.10% | 11,666 |
| 26-07-14 | €2.192 | -4.94% | 23,371 |
| 26-07-13 | €2.306 | +3.11% | 12,482 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- 0OB3 Stock
Select your edition
All financial news and data tailored to specific country editions

















